Head of U.S. Health Economics & Value Assessment (HEVA)

Role Summary

The Head of U.S. Health Economics & Value Assessment (HEVA) is a senior strategic and scientific leader responsible for shaping and executing the U.S. HEVA strategy for Sanofi’s Specialty Care portfolio, the company’s largest and most complex market and region. This role leads a team of U.S. HEVA Therapeutic Area Leads who deliver the evidence and insights needed to ensure access, inform policy, and demonstrate value throughout the product lifecycle. The U.S. HEVA Head translates global evidence into US regional impact, delivering US-specific evidence generation and dissemination, shaping payer and policymaker dialogue, and ensuring HEVA evidence directly influences pricing, access, and policy decisions.

Responsibilities

• Strategic Leadership and Market Impact: Define and execute the U.S. HEVA strategy across all Specialty Care therapeutic areas, aligned with global HEOR, U.S. Medical, and Commercial priorities; serve on leadership teams to ensure alignment between global and US strategies; translate HEVA evidence into business and policy impact; address U.S. policy and reimbursement dynamics through strategic evidence planning; represent Sanofi externally as a U.S. HEVA thought leader.
• Evidence Generation and Dissemination: Oversee design and execution of U.S.-focused HEVA, including RWE programs; lead launch and post-launch US HEVA strategies; develop compliant and impactful US evidence dissemination pathways; partner with U.S. Medical Affairs/Value & Access to ensure appropriate use of HEOR evidence; champion data-driven storytelling.
• Policy, Payer, and Stakeholder Engagement: Collaborate with Value & Access, US Medical Affairs, and Policy to deliver evidence for value frameworks and responses; partner with State Government Affairs and external advocacy groups to shape policies; lead engagement with key US policy stakeholders; support external advocacy and evidence education initiatives.
• People, Culture, and Organizational Leadership: Lead and develop a high-performing U.S. HEVA team; empower U.S. TA Leads to act as strategic partners; promote innovation, inclusion, and continuous learning; model integrity and ethical leadership.
• Performance, Integration, and Governance: Establish U.S. HEVA performance metrics; ensure alignment between U.S. and global priorities; oversee budgeting, resourcing, and operational delivery; maintain compliance with enterprise, legal, and regulatory standards in evidence generation and dissemination.

Qualifications

• Required: Advanced degree (PhD, MD, MSc, MPH, or PharmD) in a scientific discipline
• Required: Minimum of 10 years of progressive experience in health economics and outcomes research (HEOR), real-world evidence, or related evidence and policy leadership roles
• Required: Proven success leading U.S. HEOR strategy and execution across multiple therapeutic areas within large, matrixed organizations
• Required: Recognized externally as a HEOR leader with credibility among payers, policymakers, and academic peers
• Required: Deep understanding of the U.S. healthcare ecosystem, payer and policy landscape, and evolving regulatory environment
• Required: Demonstrated ability to translate evidence into business impact, influence policy, and drive access outcomes
• Required: Experience managing scientific teams and cross-functional stakeholders at senior enterprise levels
• Required: Approximately 25% travel expected, primarily domestic with occasional international trips

Skills

• Strong leadership across strategic, operational, and people dimensions with a track record of team development
• Excellent communication and influencing skills, including the ability to convey complex evidence to senior management and external stakeholders
• Deep understanding of the U.S. healthcare, policy, and regulatory environment with a commitment to compliance and ethics
• Entrepreneurial mindset and ability to develop creative solutions to complex problems

Education

• Advanced degree (PhD, MD, MSc, MPH, or PharmD) in a scientific discipline

Additional Requirements

• Approximately 25% travel expected, primarily domestic with occasional international trips